Results 261 to 270 of about 301,296 (304)
Some of the next articles are maybe not open access.

Venous Thromboembolism

2010
Pulmonary embolism is a complication of venous thrombosis. It is a major cause of morbidity and mortality, but a condition that is highly preventable and, when diagnosed, very effectively treated. Yet in the United States, more people die of pulmonary embolism each year than of AIDS. The clinician must maintain a high index of suspicion at all times in
openaire   +2 more sources

Treatment of venous thromboembolism

International Journal of Hematology, 2000
The combination of heparin and oral anticoagulants has been the treatment of choice for most patients with venous thromboembolism in the last two decades. Heparin has been proven to be effective when administered by intravenous continuous infusion or by subcutaneous injection. Oral anticoagulants should be started at the same time and heparin should be
openaire   +5 more sources

Hyperhomocysteinemia and Venous Thromboembolism

Seminars in Thrombosis and Hemostasis, 2006
Homocysteine (Hcy) is a sulfhydryl amino acid derived from the metabolic conversion of methionine, which is dependent on vitamins (folic acid, B12 and B6) as cofactors or cosubstrates. Severe hyperhomocysteinemia (homocystinuria), due to inherited metabolic defects of Hcy metabolism, is associated with very high risk of venous thromboembolism (VTE ...
openaire   +2 more sources

Cancer and venous thromboembolism

American Heart Journal, 1996
Neoplastic cells can activate the clotting system directly, thereby generating thrombin, or indirectly, by stimulating mononuclear cells to synthesize and express various procoagulants. Clinical manifestations of increased thrombin generation may be accentuated by down-regulation of endothelial cell counterregulatory mechanisms, such as decreased ...
A, Piccioli   +3 more
openaire   +2 more sources

Pregnancy and venous thromboembolism

Current Opinion in Obstetrics & Gynecology, 2014
This review provides a concise and complete overview of diagnostic work-up and treatment of venous thromboembolism in pregnancy, with attention to recent research developments and recent applicable guidelines. This may be useful for all the players of the multidisciplinary interaction needed in this disease management, namely cardiologists and ...
Ralli E, Zezza L, Caserta D.
openaire   +2 more sources

Venous thromboembolism and cancer

ANZ Journal of Surgery, 2012
AbstractBackground:  Venous thromboembolism (VTE) remains one of the most important causes of mortality and morbidity in the hospitalized patient. This is particularly evident in patients with cancer who are exposed to a four‐ to sixfold increased risk of VTE compared with those patients without cancer.Methods:  A review of the current literature was ...
Donald G, MacLellan   +2 more
openaire   +2 more sources

Olanzapine and venous thromboembolism

International Clinical Psychopharmacology, 2003
Clozapine has recently been associated with venous thromboembolism. The aim of this study was to describe three elderly patients in whom olanzapine therapy was associated with venous thromboembolism. During a 4-month period at the same psychogeriatric clinic, three elderly patients (an 89-year-old male, a 78-year-old male and an 83-year-old female ...
Staffan, Hägg   +2 more
openaire   +2 more sources

Pathogenesis of venous thromboembolism

Current Opinion in Pulmonary Medicine, 2002
Three factors are related with the pathogenesis of venous thrombosis: (1) blood stasis, (2) hypercoagulability, and (3) vessel damage. Local and systemic factors are implicated in blood stasis. Remarkable advances have been recently achieved regarding the understanding of the concept of hypercoagulability, with special emphasis to thrombophilic ...
BECATTINI, Cecilia, AGNELLI, Giancarlo
openaire   +3 more sources

NICE and venous thromboembolism

The Journal of Bone and Joint Surgery. British volume, 2010
The original guidance issued by the National Institute for Health and Clinical Excellence (NICE) concerning venous thromboembolism (VTE) and surgical patients in 2007,[1][1] caused concern among orthopaedic surgeons.
openaire   +2 more sources

Prevention of Venous Thromboembolism

Clinical Orthopaedics and Related Research, 1987
Pulmonary embolism is still the largest single cause of postoperative mortality (1%-3%) from major reconstructive lower extremity joint surgery. It is imperative that the surgeon who deals with trauma and musculoskeletal disorders be informed about the prevention of venous thromboembolic disease, recognize the magnitude of the problem, and then take ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy